Molecular mechanisms of the mitochondrial permeability transition
线粒体通透性转变的分子机制
基本信息
- 批准号:10728363
- 负责人:
- 金额:$ 12.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:Animal DiseasesBiological AssayCalciumCell DeathCell Membrane PermeabilityCellsCessation of lifeComplexCoupledDiseaseDrug TargetingElectrophysiology (science)Energy-Generating ResourcesEnsureEukaryotic CellEventFunctional disorderGenerationsGoalsHomeostasisInner mitochondrial membraneKnowledgeLinkMeasurementMeasuresMembrane PotentialsMethodsMitochondriaModelingMolecularMyocardial InfarctionNerve DegenerationOxidative PhosphorylationPathologicPathway interactionsPermeabilityPhosphorylationPotential EnergyPreventionProcessRegulationResearchRespiratory ChainSeveritiesStressStrokeTherapeuticTissueselectrical potentialmitochondrial membraneoxidationpatch clamppreventprogramstherapeutic development
项目摘要
The overarching goal of my research program is to identify and characterize molecular mechanisms
responsible for stress-induced permeabilization of the mitochondrial inner membrane. In most eukaryotic
cells, mitochondria are the primary source of the energy that they provide in the form of ATP by
performing oxidative phosphorylation (OXPHOS). OXPHOS is a two-step process. First, substrate
oxidation by the respiratory chain results in the generation of the electrical potential on the mitochondrial
inner membrane. This potential energy drives generation of ATP by the phosphorylation of ADP at the
ATP synthase complex. To prevent energy dissipation and ensure that OXPHOS is efficient mitochondrial
inner membrane permeability should be tightly controlled and maintained at low levels. Stress conditions
associated with dysregulation of calcium and ROS homeostasis can lead to an increase in mitochondrial
inner membrane permeability – a phenomenon known as Mitochondrial Permeability Transition (mPT).
mPT causes dissipation of the membrane potential and loss of mitochondrial ATP-generating capacity
leading to cell dysfunction and death. mPT is critically involved in a broad spectrum of diseases ranging
from heart attack to neurodegeneration. Prevention of mPT is highly protective against cell death and
tissue damage suggesting high therapeutics potential. However, molecular mechanisms of mPT are not
well understood, and this gap in knowledge prevents mPT from being a drug target. Over the past five
years, we demonstrated that mPT is a multifaceted phenomenon and depending on the disease type and
stress severity, it can occur through different pathways. The central goal of our research program is to
identify the link between specific molecular mechanisms of mPT and specific stress conditions. We have
already established several original animal and cell disease-relevant models causing different types of
mPT. In our approach, a variety of methods that measure the mPT and tissue damage at the organismal,
cellular and mitochondrial levels are coupled with a number of our original electrophysiological (patch-
clamp) assays that allow direct measurement of mPT at the level of mitochondrial membranes and give
us a unique opportunity to dissect and characterize its multiple identities and regulation. The results of
our study will provide a detailed understanding of one of the most critical events in cell death cascades
and will bring an essential framework for the development of therapeutically approaches that will
selectively target mPT.
我的研究计划的首要目标是确定和表征分子机制
负责应激诱导的线粒体内膜透化。在大多数真核生物中,
线粒体是能量的主要来源,它们以ATP的形式提供能量,
进行氧化磷酸化(OXPHOS)。OXPHOS是一个两步过程。第一,基板
呼吸链的氧化导致在线粒体上产生电势
内膜这种势能通过ADP的磷酸化驱动ATP的产生,
ATP合成酶复合物。为了防止能量耗散,并确保OXPHOS是高效的线粒体
应严格控制内膜渗透性并将其维持在低水平。应力条件
与钙和活性氧稳态失调相关的可能导致线粒体增加
内膜通透性-一种称为线粒体通透性转换(mPT)的现象。
mPT引起膜电位的耗散和线粒体ATP生成能力的丧失
导致细胞功能障碍和死亡。mPT与多种疾病密切相关,
从心脏病发作到神经退化预防mPT对细胞死亡具有高度保护作用,
组织损伤提示高治疗潜力。然而,mPT的分子机制不是
这种知识上的差距阻碍了mPT成为药物靶点。过去五
多年来,我们证明了mPT是一种多方面的现象,取决于疾病类型,
压力严重,它可以通过不同的途径发生。我们研究计划的中心目标是
确定mPT的特定分子机制与特定应激条件之间的联系。我们有
已经建立了几种原始的动物和细胞疾病相关模型,导致不同类型的
mPT。在我们的方法中,各种测量mPT和组织损伤的方法,
细胞和线粒体水平与许多我们原始的电生理学(补丁,
钳)测定,其允许在线粒体膜水平直接测量mPT,并给出
我们有一个独特的机会,剖析和特点的多重身份和监管。的结果
我们的研究将提供细胞死亡级联中最关键事件之一的详细了解
并将为治疗方法的发展带来一个基本框架,
选择性靶向mPT。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Evgeny Pavlov其他文献
Evgeny Pavlov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Evgeny Pavlov', 18)}}的其他基金
Molecular mechanisms of the mitochondrial permeability transition
线粒体通透性转变的分子机制
- 批准号:
10322360 - 财政年份:2021
- 资助金额:
$ 12.28万 - 项目类别:
Molecular mechanisms of the mitochondrial permeability transition
线粒体通透性转变的分子机制
- 批准号:
10557809 - 财政年份:2021
- 资助金额:
$ 12.28万 - 项目类别:
Molecular mechanisms of the mitochondrial permeability transition
线粒体通透性转变的分子机制
- 批准号:
10551711 - 财政年份:2021
- 资助金额:
$ 12.28万 - 项目类别:
Molecular composition of the mitochondrial permeability transition pore
线粒体通透性转换孔的分子组成
- 批准号:
10004077 - 财政年份:2016
- 资助金额:
$ 12.28万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 12.28万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 12.28万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 12.28万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 12.28万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 12.28万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 12.28万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 12.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 12.28万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 12.28万 - 项目类别:
Postdoctoral Fellowships